Recombinant Human GPX1 Protein，His

GPX1, or Glutathione Peroxidase 1, is an essential antioxidant enzyme that plays a crucial role in cellular defense against oxidative stress. It catalyzes the reduction of hydrogen peroxide and hydroperoxides using glutathione, thereby maintaining redox homeostasis and protecting cells from oxidative damage. Research has identified GPX1 as a significant factor in various physiological processes, including inflammation, aging, and the progression of numerous diseases, such as cancer and neurodegenerative disorders. Genetic variations in the GPX1 gene can influence enzyme activity and have been associated with altered disease susceptibility and outcomes. Due to its importance, GPX1 has emerged as a target for therapeutic interventions aimed at enhancing antioxidant defenses. The study of recombinant GPX1 proteins is pivotal for understanding its functional mechanisms, potential regulatory pathways, and interactions with other cellular components. By producing GPX1 in a recombinant form, researchers can investigate the enzyme's biochemical properties, assess the impacts of specific mutations, and evaluate the potential for developing GPX1-based treatments. Additionally, recombinant GPX1 can serve as a valuable tool in pharmaceutical applications and for the development of diagnostic assays aimed at assessing oxidative stress in various health conditions. Thus, ongoing research into GPX1 and its recombinant forms holds promise for advancing our understanding of oxidative stress-related diseases and improving therapeutic strategies.